Seres Therapeutics Inc

-0.72 (-3.19%)
Earnings Announcements

Seres Therapeutics Reports Q1 Loss Per Share $0.39

Published: 05/04/2021 11:24 GMT
Seres Therapeutics Inc (MCRB) - Seres Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Updates.
Q1 Loss per Share $0.39.
Q1 Earnings per Share View $-0.31 -- Refinitiv Ibes Data (analyst estimates).
Q1 Total Revenue $5.7 Million Versus $8.2 Million Last Year.
Q1 Revenue View $6.4 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $5.16 Million
Adjusted EPS is expected to be -$0.39

Next Quarter Revenue Guidance is expected to be $5.32 Million
Next Quarter EPS Guidance is expected to be -$0.41

More details on our Analysts Page.